| 名称
|
ANP (1-28), human
|
| 编码
|
|
| 别名
|
ANP (1-28), human
|
| 纯度
|
80%，90%，95%，98%，99%
|
| 重量
|
1mg,5mg,10mg,50mg,100mg,1g
|
| 序列（单字母缩写）
|
SLRRSSCFGGRMDRIGAQSGLGCNSFRY (C7&C23 bridge)
|
| 序列（三字母缩写）
|
H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (trifluoroacetate salt)(Cys7 and 23 bridge)
|
| 基本描述
|
Atriopeptin is synthesized primarily in cardiac atria, acts in opposition to angiotensin II. When blood volume overload, Atriopeptin is released to act at the nephron to increase salt and water excretion, lowering blood volume and blood pressure.
|
| 溶解度
|
|
| 分子量
|
3080.5
|
| 化学式
|
C127H203N45O39S3
|
| 存储条件
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| 注释
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
N. Chino et al., Peptide Chemistry, 1984, 241, (1985)
|
| C端
|
|
| N端
|
|
| 化学桥
|
(Cys7 and 23 bridge)
|